Please check your internet connection and try again.
# Megacv Duo
## Overview
Megacv Duo is a fixed-dose combination antibiotic containing **Amoxicillin** and **Potassium Clavulanate (Clavulanic Acid)**. It is a beta-lactamase inhibitor combination designed to expand the spectrum of amoxicillin to include beta-lactamase-producing bacteria. "Duo" typically denotes a 7:1 or 4:1 ratio formulation depending on the specific product local availability.
## Primary Indications
* Community-acquired pneumonia
* Acute bacterial sinusitis
* Acute otitis media
* Skin and soft tissue infections
* Urinary tract infections (if susceptibility confirmed)
## Adult Dosing
* **Standard dose:** Typically 875 mg amoxicillin/125 mg clavulanate twice daily.
* **High dose (for resistant S. pneumoniae):** Some protocols suggest 875 mg amoxicillin/125 mg clavulanate every 8 hours.
* **Maximum:** Do not exceed 2000 mg of amoxicillin per dose or 6000 mg per day. Always verify the clavulanate limit to avoid hepatotoxicity.
## Pediatric Dosing
Dosing is based on the **amoxicillin component**.
* **Standard:** 25–45 mg/kg/day divided every 12 hours.
* **High dose (Otitis media/severe infections):** 80–90 mg/kg/day divided every 12 hours.
* **Note:** Use the specific suspension ratio (e.g., 400mg/57mg per 5mL or 600mg/42.9mg per 5mL) provided by the manufacturer to reach these body-weight-based targets.
## Dose Adjustments
* **Renal Impairment (CrCl < 30 mL/min):** Avoid extended-release formulations. Require interval adjustments or dose reduction based on CrCl. Use with extreme caution if CrCl < 10 mL/min.
* **Hepatic Impairment:** Use with caution; monitor liver function periodically.
## Contraindications
* Known hypersensitivity to penicillins or any component of the formulation.
* History of cholestatic jaundice or hepatic dysfunction associated with amoxicillin/clavulanate therapy.
* History of severe allergic reaction (anaphylaxis) to any beta-lactam (cephalosporins, carbapenems, monobactams).
## Adverse Effects
* **Common:** Diarrhea (significantly reduced if taken with food), nausea, vomiting, skin rash (non-allergic "amoxicillin rash").
* **Serious:** *Clostridioides difficile*-associated diarrhea, hepatotoxicity (cholestatic jaundice), severe hypersensitivity reactions (DRESS syndrome, anaphylaxis).
## Key Drug Interactions
* **Methotrexate:** May decrease renal clearance, increasing risk of methotrexate toxicity.
* **Warfarin:** May increase INR/risk of bleeding; monitor PT/INR closely.
* **Oral Contraceptives:** May reduce efficacy; advise use of backup barrier method.
* **Probenecid:** Increases and prolongs blood levels of amoxicillin.
## Monitoring
* Renal and hepatic function (AST/ALT, Bilirubin) during prolonged therapy (>14 days).
* Signs and symptoms of hypersensitivity.
* Resolution of infection symptoms.
* Monitor for persistent watery or bloody diarrhea (C. diff risk).
## Clinical Pearls
* **Take with food:** Always administer at the start of a meal to minimize gastrointestinal upset and maximize absorption.
* **Ratio Matters:** Pay close attention to the strength; 250 mg tablets are not bioequivalent to 875 mg/125 mg tablets due to the clavulanate content.
* **Not interchangeable:** Products with different amoxicillin:clavulanate ratios are not interchangeable.
* **Duration:** Limit therapy to the shortest duration necessary to prevent resistance and secondary infections.
***
**Educational Disclaimer:** This summary is for informational purposes only and does not replace professional medical judgment. Dosing may vary based on local resistance patterns, national guidelines (e.g., IDSA), and specific brand formulations. Always verify the current prescribing information and confirm dosages against the patient's renal function and clinical status before prescribing.
